HealthCare Royalty Partners Company Profile

07:16 EDT 23rd March 2018 | BioPortfolio

HealthCare Royalty Partners (HCRP) is a global healthcare investment firm focused on investing primarily in commercial stage healthcare product assets. HCRP manages over $3 billion and is headquartered in Stamford, CT. Over the past decade, HCRP's co-founders have completed more than 60 healthcare investments totaling more than $2.6 billion of capital. For more information, visit

News Articles [964 Associated News Articles listed on BioPortfolio]

Albireo sells HealthCare Royalty Partners its elobixibat royalty rights in Japan

Albireo Pharma Inc., through its Elobix subsidiary, entered into an agreement with HealthCare Royalty Partners to monetize its royalty rights for the constipation drug elobixibat in Japan.

Acorda sells Fampyra royalties to HealthCare Royalty Partners for $40mm

HealthCare Royalty Partners (HCRP) is providing Acorda Therapeutics Inc. with $40mm in exchange for royalty revenues (up to an agreed upon threshold) due to Acorda on ex-US sales of Fampyra (prolonged...

Agenus enters $230mm royalty sale agreement with Healthcare Royalty

Immuno-oncology firm Agenus Inc. entered a $230mm royalty sale agreement with Healthcare Royalty Partners, which will pay $190mm in cash up front in exchange for royalties Agenus is eligible to receiv...

Albireo Announces Royalty Monetization Agreement with HealthCare Royalty Partners for Elobixibat in Japan

— Albireo subsidiary eligible to receive up to $60 million under agreement — — Decision on Japanese New Drug Application for elobixibat expected in first half of 2018 — BOSTON, Jan. 03,...

Agenus to sell Stimulon adjuvant to HealthCare

HealthCare Royalty Partners will gain Agenus' royalty rights on sales of vaccines from GlaxoSmithKline containing Agenus' QS- -More- 

Agenus Announces $230M Royalty Monetization With HealthCare Royalty Partners

The transaction is comprised of $190 million of cash proceeds at closing plus up to $40 million in milestone payments

Albireo in elobixibat royalty deal with HealthCare Royalty

HealthCare Royalty in vaccine royalty deal with Agenus

Drugs and Medications [477 Associated Drugs and Medications listed on BioPortfolio]

Sweatblock [DC Alpine Partners, LLC DBA: Sweatblock]

SWEATBLOCK Clinical Strength Antiperspirant

Day cream mattifying hydrator [MOSAIC MARKETING PARTNERS LLC]


Ribavirin [Cadila Healthcare Limited]

These highlights do not include all the information needed to use ribavirin safely and effectively. See full prescribing information for ribavirin. Initial U.S. Approval: 2002

Ribavirin [Sandoz Inc]

These highlights do not include all the information needed to use RIBAVIRIN TABLETS safely and effectively. See full prescribing information for RIBAVIRIN TABLETS. Ribavirin Tablets, oralInitial U.S. ...

Ribavirin [Zydus Pharmaceuticals (USA) Inc.]

These highlights do not include all the information needed to use ribavirin safely and effectively. See full prescribing information for ribavirin. Initial U.S. Approval: 2002

PubMed Articles [1233 Associated PubMed Articles listed on BioPortfolio]

Partners' Overestimation of Patients' Pain Severity: Relationships with Partners' Interpersonal Responses.

The present study examined whether concordance between patients' and their partners' reports of patient pain severity relates to partners' social support and behavioral responses in couples coping wit...

The effect of partners' education on women's reproductive and maternal health in developing countries.

The effect of partners' education on women's and children's health in developing countries has received relatively little attention to date. This study uses couple data from 37 recent Demographic and ...

Invited Commentary. The Royalty of Evidence: The Randomized Control Trials.

Current Age, Age at First Sex, Age at First Homelessness, and HIV Risk Perceptions Predict Sexual Risk Behaviors among Sexually Active Homeless Adults.

While HIV disproportionately impacts homeless individuals, little is known about the prevalence of HIV risk behaviors in the southwest and how age factors and HIV risk perceptions influence sexual ris...

The Hidden Roles That Management Partners Play In Accountable Care Organizations.

Accountable care organizations (ACOs) are often discussed and promoted as driven by physicians, hospitals, and other health care providers. However, because of the flexible nature of ACO contracts, ma...

Clinical Trials [1189 Associated Clinical Trials listed on BioPortfolio]

Comparative Effectiveness of Two Tobacco Cessation Interventions for Employees of Partners HealthCare, Inc.

Specific Aim: To conduct a randomized controlled trial among permanent employees of Partners HealthCare, Inc., and their adult dependents, who are current tobacco smokers. The trial will c...

Ferumoxytol as a Contrast Agent for Pulmonary Magnetic Resonance Angiography

This proposal is based on findings from our previous work involving ferumoxytol-enhanced cardiac magnetic resonance angiography. The resolution of the pulmonary vasculature based on our pr...

Partners Demonstration Project of PrEP and ART

The purpose of this protocol is to determine user preferences for antiretroviral therapy (ART) for HIV-1 infected partners and pre-exposure prophylaxis (PrEP) HIV-1 un-infected partners an...

To Develop a Validated Program and Use it to Evaluate Patients Post-operatively

Annually, the Department of Anesthesiology, Siriraj hospital has responsibilities to take care of more than 50,000 patients peri-operatively. According to Maslow's hierarchy of needs; huma...

Teachers and Parents as Partners During Middle School

There are two aims of this study (a) to examine the effect of Teachers and Parents as Partners on student, parent, and teacher outcomes in middle school and (b) identify barriers and facil...

Companies [2810 Associated Companies listed on BioPortfolio]

Cowen Healthcare Royalty Partners

Cowen Healthcare Royalty Partners is a global healthcare private equity firm that invests principally in commercial-stage biopharmaceutical and medical device companies and products, through the purch...

HealthCare Royalty Partners

HealthCare Royalty Partners (HCRP) is a global healthcare investment firm focused on investing primarily in commercial stage healthcare product assets. HCRP manages over $3 billio...


A pioneer in the field when launched in 1992, Drug Royalty was the first firm to provide royalty-based financing in the life sciences sector and the first to complete royalty transactions with invento...

Capital Royalty L.P.

Our diversified team of investment professionals is dedicated to meeting the specific needs of each client, and with our extensive experience in the healthcare and financial industries, Capital Royalt...

Drug Royalty

Drug Royalty is an innovative and profitable Canadian company involved in the international life science industry. Established in 1992, DRC was designed to participate in the growth from the global he...

More Information about "HealthCare Royalty Partners" on BioPortfolio

We have published hundreds of HealthCare Royalty Partners news stories on BioPortfolio along with dozens of HealthCare Royalty Partners Clinical Trials and PubMed Articles about HealthCare Royalty Partners for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of HealthCare Royalty Partners Companies in our database. You can also find out about relevant HealthCare Royalty Partners Drugs and Medications on this site too.

Quick Search


Relevant Topic

Health care (or healthcare) is the diagnosis, treatment, and prevention of disease, illness, injury, and other physical and mental impairments in humans. Health care is delivered by practitioners in medicine, chiropractic, dentistry, nursing, pharmacy, a...

Corporate Database Quicklinks

Searches Linking to this Company Record